Novartis India Ltd

Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On August 17, 2026

Outcome of the meeting of the Board of Directors of the Company held on August 17, 2026

Others / Outcome without intimation View filing →

Board Meeting Outcome for Outcome Of The Board Meeting Held On August 07, 2026

Intimation of the outcome of the Board Meeting held today i.e. August 07, 2026

Others / Outcome without intimation View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for WaveRise Investments Ltd

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Board Meeting Outcome for Outcome Of The 245Th Meeting Of The Board Of Directors Of Novartis India Limited ("The Company") Held Today, Wednesday, July 29, 2026.

Outcome of the 245th Meeting of the Board of Directors of Novartis India Limited ("the Company") held today, Wednesday, July 29, 2026.

Others / Outcome without intimation View filing →

Intimation Under Regulation 31A (10) And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, ("SEBI Listing Regulations").

Intimation under Regulation 31A (10) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").

Company Update / General View filing →

Disclosure In Terms Of Regulation 7(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015.

Disclosure in terms of Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015

Company Update / General View filing →

Disclosure In Terms Of Regulation 29(2) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) ("SAST"), 2015.

Disclosure in terms of Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ("SAST") Regulations, 2015.

Company Update / General View filing →

Change In Control Of The Novartis India Limited ("The Company").

The Board of Directors of Novartis India Limited ("the Company') in its meeting today, July 29, 2026 approved the Change in Control of the Company.

Company Update / General View filing →

Resignation of Chairman

The Board of Directors of Novartis India Limited ("the Company") at its meeting held today i.e, Wednesday, July 29, 2026 took note of the Resignation of Mr. Christopher David Snook as ....

Company Update / Resignation of Chairman View filing →

Outcome Of The 246Th Meeting Of The Board Of Directors Held On Today I.E, Wednesday, July 29, 2026.

Outcome of the 246th Board Meeting of the Board of Directors of Novartis India Limited held today i.e, Wednesday, July 29, 2026.

Company Update / General View filing →

Outcome Of The 247Th Meeting Of The Board Of Directors Held Today, I.E, Wednesday, July 29, 2026.

Outcome of the 247th meeting of the Board of Directors held today, i.e, Wednesday, July 29, 2026.

Company Update / General View filing →

Newspaper Publication

Intimation of Newspaper Advertisement by Novartis India Limited ("the Company") regarding the publication of Unaudited Financial Results of the Company for the Quarter ended June 30, 2026.

Company Update / Newspaper Publication View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, issued to Novartis India Limited ("The Company") ....

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Post-Offer advertisement

Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India ....

Company Update / General View filing →

Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Novartis India Limited ("The Company").

Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

Board Meeting / Board Meeting View filing →

Closure of Trading Window

Intimation of the Closure of the Trading Window for Novartis India Limited ("the Company") for the quarter ended June 30, 2026.

Insider Trading / SAST / Closure of Trading Window View filing →

Pre-Offer Advertisement & Corrigendum to Detailed Public Statement

Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange Board of India (Substantial ....

Company Update / General View filing →

Open Offer - Updates

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 relating to the Receipt of the Letter of Offer from Axis Capital Limited (Manager ....

Company Update / Open Offer - Updates View filing →

Open Offer - Updates

Intimation of Recommendations by the Committee of Independent Directors ("IDC") pursuant to Regulation 26(7) of the SEBI (SAST) Regulations, 2011.

Company Update / Open Offer - Updates View filing →

Letter of Offer

Axis Capital Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer to the public shareholders of Novartis India Ltd ("Target Company").

Company Update / General View filing →